Antibiotic Treatment clinical trials

Explore recruiting antibiotic treatment clinical trials.

Recruiting antibiotic treatment studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Antibiotic Treatment trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized controlled non-inferiority trial comparing 7 versus 14 days of ciprofloxacin for male urinary tract infections with systemic involvement.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized (SHORTEN-2) clinical trial with a DOOR/RADAR analysis.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Antibiotic Treatment Trial in Acute Coronary Syndrome

Finland

Phase III and phase IV (Integrated) EU CTIS Study details

Treatment of penicillin susceptible Staphylococcus aureus bacteraemia with bensylpenicillin versus cloxacillin – a randomized controlled trial

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

SHORTCUT - Efficacy of 7 days versus 14 days of antibiotic therapy for acute pyelonephritis in kidney transplant recipients, a multicenter randomized non-inferiority trial

France

Therapeutic use (Phase IV) EU CTIS Study details

CUSTOMIZED ANTIBIOTIC TREATMENT DURATION AMONG HOSPITALIZED PATIENTS WITH MODERATELY SEVERE COMMUNITY-ACQUIRED PNEUMONIA [CAT-CAP]

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Antibiotic Treatment trials by city

Antibiotic Treatment in Toronto Antibiotic Treatment in Vancouver Antibiotic Treatment in Montreal Antibiotic Treatment in Calgary Antibiotic Treatment in Edmonton Antibiotic Treatment in Ottawa Antibiotic Treatment in Winnipeg Antibiotic Treatment in Quebec City Antibiotic Treatment in Hamilton Antibiotic Treatment in Kitchener Antibiotic Treatment in London Antibiotic Treatment in Halifax Antibiotic Treatment in New York Antibiotic Treatment in Los Angeles Antibiotic Treatment in Chicago Antibiotic Treatment in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease